Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Twin Cities Pain Clinic Offers Only FDA-Approved Neurostimulation Treatment for Diabetic Neuropathy

Twin Cities Pain Clinic, based out of Edina, Minnesota, is proud to offer the newly approved, nondrug treatment from Nevro for treating patients suffering from painful diabetic neuropathy (PDN). HFX for PDN is a specific form of spinal cord stimulation therapy and is the only spinal cord stimulation system approved by the Food and Drug Administration (FDA) with a specific indication for PDN. Diabetic neuropathy is the most common chronic complication of diabetes, which is a disease that impacts more than 34 million Americans. Many people with the condition experience pain including numbness, burning and stabbing in the hands and feet. People in our community suffering from PDN now have access to a brand-new therapy option to provide lasting, effective relief from these symptoms. Twin Cities Pain Clinic founder and Medical Director, Dr. Andrew J. Will, will be happy to provide comments and perform an interview to further discuss this innovative treatment option for people with PDN.


News provided by

Twin Cities Pain Clinic

Nov 05, 2021, 09:00 ET

Share this article

Share toX

Share this article

Share toX


EDINA, Minn., Nov. 5, 2021 /PRNewswire-PRWeb/ -- Twin Cities Pain Clinic is now proudly offering spinal cord stimulation (SCS) therapy for the treatment of painful diabetic neuropathy (PDN). The technology is a newly approved nondrug treatment for PDN and is the only SCS system with a specific indication to treat the condition. More than 34 million people in the U.S. have diabetes [1], and it's estimated that 20-25% of people with diabetes will develop PDN [2]. The condition is associated with a wide range of symptoms including pain in the limbs described as burning, freezing, stabbing, shooting, hypersensitivity or deep aching [3]. Traditional treatment options for PDN include over-the-counter medications, prescription medications, physical therapy and injections, but for many people, these options are inadequate for long-term relief.

HFX for PDN is the only spinal cord stimulation system approved by the Food and Drug Administration (FDA) with a specific indication for PDN. HFX is a comprehensive solution that includes a Senza spinal cord stimulation system and support services for the treatment of chronic pain. HFX for PDN means that a patient has been implanted with a Senza System and programmed to include a frequency of 10 kHz.

“HFX for PDN offers a new option to alleviate the agonizing and persistent symptoms of this condition," said Dr. Andrew J. Will, founder and medical director of Twin Cities Pain Clinic. "There is no other therapy like this, and I believe it can make a real difference for our patients with PDN.”

Post this

The Senza device is implanted during a quick and minimally invasive procedure, and then begins delivering mild pulses at a high frequency directly to the spinal cord to stop pain signals from reaching the brain. In a recent study, 92% of patients reported high satisfaction with the therapy [4].

"People with PDN know it to be a cruel addition to the chronic disease they must fight every day," said Dr. Andrew J. Will, founder and medical director of Twin Cities Pain Clinic. "HFX for PDN offers a new option to alleviate this agonizing and persistent sensation. There is no other therapy like this, and I believe it can make a real difference for our patients suffering from PDN."

Twin Cities Pain Clinic is one of the foremost authorities on neurostimulation therapy in the country, performing hundreds of procedures every year and partaking in extensive research studies to advance stimulation technology. On numerous occasions, they have been hand-picked my medical device companies to be the first pain group in the state of Minnesota to perform their latest pain treatments.

Twin Cities Pain Clinic was recently recognized as the best pain clinic in the state, as voted by the residents of Minnesota in the Star Tribune's 2021 Minnesota's Best awards. Their associated ambulatory surgery center in Edina, Twin Cities Surgery Center, also took top honors in the contest, being voted the best surgery center in the state.

For important safety information regarding the new HFX treatment, please visit http://www.HFXforPDN.com.

About Twin Cities Pain Clinic
Twin Cities Pain Clinic is a comprehensive pain management organization that has been helping patients achieve relief from chronic pain since 2003. As a leading authority in the field of chronic pain management, our organization is committed to providing every patient with a customized treatment plan consisting of the most advanced and effective therapies to provide optimal outcomes. To learn more or schedule an appointment, go online to http://www.twincitiespainclinic.com or call (952) 841-2345.

[1] CDC 2020 National Diabetes Statistics
[2] Schmader KE et al. Clin J Pain. 2002;18(6):350-354
[3] Peltier A, et al. BMJ. 2014;348g1799.
[4] Petersen EA, et al. JAMA Neurol. Published online April 05, 2021. doi:10.1001/jamaneurol.2021.0538

Media Contact

Jeff Blanchard, Twin Cities Pain Clinic, 1 9522043556, [email protected]

SOURCE Twin Cities Pain Clinic

Related Links

http://www.twincitiespainclinic.com

Modal title

People with Painful Diabetic Neuropathy Can Now Receive the Only Spinal Cord Stimulator FDA-Approved for the Condition at Twin Cities Pain Clinic
View PDF
People with Painful Diabetic Neuropathy Can Now Receive the Only Spinal Cord Stimulator FDA-Approved for the Condition at Twin Cities Pain Clinic
People with Painful Diabetic Neuropathy Can Now Receive the Only Spinal Cord Stimulator FDA-Approved for the Condition at Twin Cities Pain Clinic

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.